Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G Increases Stake In Regeneron; Vertex Rides On Novartis Endorsement

Executive Summary

Procter & Gamble's stake in Regeneron will increase to 16% with the purchase of an additional 573,630 Regeneron shares.

You may also be interested in...

P&G Taps Lafley To Turn "Tide" In Earnings: Pepper Returns As Chairman

Procter & Gamble CEO-elect A.G. Lafley will inherit the task of settling the appropriate size for P&G's investment in the pharmaceutical business.

Geltex' Welchol Combination With Lipitor Lowers LDL Cholesterol 48%

Geltex' bile acid sequestrant Welchol (colesevelam) reduces LDL cholesterol by 48% in combination with Warner-Lambert/Pfizer's Lipitor (atorvastatin).

Novartis Deal With Vertex, NYSE Listing Bolster U.S. Presence

Novartis has augmented its U.S. research profile with a long-term drug discovery deal with Cambridge, Mass.-based Vertex Pharmaceuticals.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts